# Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin in Humans

> **NCT01969994** · NA · COMPLETED · sponsor: **The Institutes for Pharmaceutical Discovery, LLC** · enrollment: 12 (actual)

## Conditions studied

- ADME

## Interventions

- **OTHER:** Controlled dietary background
- **OTHER:** (-)-[2-14C]epicatechin intake

## Key facts

- **NCT ID:** NCT01969994
- **Lead sponsor:** The Institutes for Pharmaceutical Discovery, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01969994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01969994, "Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin in Humans". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01969994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*